Clinical Trials Browser

Phase 1 × Completed × Breast Cancer Metastatic × Clear all

NCT04509596 2025-04-01

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Phase 1 Completed

Breast Cancer Metastatic